CEO
Hi, I am the Director of Organ Transplant and Cancer Surgery with House Medicine. Both organ transplant and cancer are very complex diseases that have significant impacts on patients and their families. I am very committed and focused on tailoring and personalizing patient care as each person’s journey is unique to them, treating each patient individually. An important part of your care often requires support from your family and friends and I encourage their involvement in the process.
I have performed thousands of extremely complex transplants and cancer surgeries in the last decade, many which have been second opinions. I have been the author of over 100 peer reviewed articles/abstracts, an invited guest speaker numerous times, and expert panelist. In addition, I have been awarded multimillion dollar National Research Grants and been the Principle Investigator of the most cutting-edge cancer and transplant trials.
I am passionate about providing the highest quality with the most advanced technology to all patients. I have led and participated in over 30 national and international humanitarian outreach medical missions over the last 10 years and am eager to continue providing service to those in need and lack access.
Medical Director
“I am an oncologist who specializes in the treatment of patients with complex gastrointestinal malignancies. Treatment of these cancers can be challenging and have an impact on both the patient and their family. I understand that providing comprehensive care to patients and families struggling with these complex cancers requires a personalized and wholistic approach. I am therefore committed to delivering whole-person care, that provides hope, integrates personalized medicine, and offers access to innovative treatments through clinical trials, all while remembering the importance of a person’s quality of life. These are guiding principles for our cancer team at House Medicine.”
Dr. Shinde is the Director of Hematology and Oncology at House Medicine. He earned his Bachelor of Science in neuroscience, with honors, from UCLA and went on to earn his medical degree from the University of Southern California. While he was in medical school, his interest in understanding the economics behind healthcare and strategies for addressing health disparities led to his completion of a Master of Business Administration from University of Southern California and a Master in Public Health from Harvard University, with a focus on health administration and policy. Afterward, he completed a residency in Internal Medicine at Cedars-Sinai Medical Center. Dr. Shinde went on to complete a fellowship in Hospice and Palliative Medicine at San Diego Hospice and the Institute for Palliative Medicine, and a fellowship in Hematology and Oncology at City of Hope/Harbor-UCLA Medical Center. He is an Assistant Professor of Medicine at the UCLA Geffen School of Medicine, and provides clinical care with privileges at multiple hospitals in Los Angeles. Dr. Shinde’s clinical focus is twofold: along with colleagues in surgery, gastroenterology, radiation oncology and radiology, he participates in a multidisciplinary team to provide oncologic care to patients with gastrointestinal malignancies; he also provide supportive and palliative care services to patients and families receiving care for complex and advanced illnesses, including those undergoing curative therapies. Dr. Shinde’s current research interests include evaluating novel therapies for the treatment of liver, bile duct, and pancreatic cancers, identifying novel therapeutic targets through tissue genomics/proteomics, improving patient quality of life through optimization of supportive care, and utilizing wearable and other novel technologies to improve patient outcomes. He has presented his research on all of these topics at international symposia and published in peer review journals.